Results from BIG D-FOOT study using STIMULAN® when treating DFO to be presented at EBJIS 2025

Biocomposites Ltd United States of America United Kingdom

Randomised, double-blinded, controlled BIG D-FOOT study demonstrates that local antibiotic delivery using STIMULAN® significantly reduces post-surgical infective complications in patients with diabetic foot osteomyelitis (DFO)Biocomposites symposium will explore best practice treatment strategies for complex infections and share findings from the BIG D FOOT studyto learn more.

About EBJIS

The European Bone & Joint Infection Society (EBJIS) is a dedicated community of medical professionals and scientists committed to advancing knowledge and fostering excellence in the prevention and treatment of musculoskeletal infections. Its annual meeting is a premier event bringing together experts, practitioners, and industry leaders for high-level scientific exchange and networking. For more information, visit https://ebjis.org/ebjis2025/ 

View original content:https://www.prnewswire.co.uk/news-releases/results-from-big-d-foot-study-using-stimulan-when-treating-dfo-to-be-presented-at-ebjis-2025-302549606.html